Oral angiotensin-(1–7) formulation attenuates structural alterations in established emphysema and protects against subsequent allergic airway inflammation
Oral angiotensin-(1–7) formulation attenuates structural alterations in established emphysema and protects against subsequent allergic airway inflammation. // Life Sciences. – URL: https://www.sciencedirect.com/science/article/pii/S0024320526005837?dgcid=rss_sd_all
Oral angiotensin-(1–7) formulation attenuates structural alterations in established emphysema and protects against subsequent allergic airway inflammation. Life Sciences. https://www.sciencedirect.com/science/article/pii/S0024320526005837?dgcid=rss_sd_all
“Oral angiotensin-(1–7) formulation attenuates structural alterations in established emphysema and protects against subsequent allergic airway inflammation.” Life Sciences.
@article{article5490,
title = {Oral angiotensin-(1–7) formulation attenuates structural alterations in established emphysema and protects against subsequent allergic airway inflammation},
journal = {Life Sciences},
url = {https://www.sciencedirect.com/science/article/pii/S0024320526005837?dgcid=rss_sd_all}
}